Publicaciones en las que colabora con Joaquín Fra Rodríguez (22)

2011

  1. Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: A phase Ib study

    International Journal of Gynecological Cancer, Vol. 21, Núm. 3, pp. 478-485

2010

  1. Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: Study based on experience at the Hospital Universitario Central de Asturias

    Clinical and Translational Oncology, Vol. 12, Núm. 8, pp. 562-567

2008

  1. Pulmonary toxicity in patients treated with gemcitabine plus vinorelbine or docetaxel for advanced non-small cell lung cancer: Outcome data on a randomized phase II study

    Investigational New Drugs, Vol. 26, Núm. 1, pp. 67-74

2007

  1. Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): Results of a prospective randomized study

    Lung Cancer, Vol. 55, Núm. 2, pp. 173-180

  2. Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas

    Cancer Chemotherapy and Pharmacology, Vol. 59, Núm. 2, pp. 251-259

2006

  1. Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

    Investigational New Drugs, Vol. 24, Núm. 3, pp. 241-248

  2. Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: A GEIS study

    British Journal of Cancer, Vol. 94, Núm. 12, pp. 1797-1802

  3. Radioterapia torácica con 70 Gy concurrente con docetaxel o paclitaxel semanal tras quimioterapia de inducción en pacientes con carcinoma de pulmón no microcítico localmente avanzado. Estudio prospectivo de tolerancia y eficacia

    Oncologia, Vol. 29, Núm. 10, pp. 412-418

  4. Tratamiento adyuvante en pacientes diagnosticados de carcinoma no microcítico de pulmón: Estado de la evidencia científica

    Oncologia, Vol. 29, Núm. 9, pp. 24-33

  5. Tratamiento adyuvante en pacientes diagnosticados de carcinoma no microcítico de pulmón: estado de la evidencia científica

    Oncología, Vol. 29, Núm. 9, pp. 24-33

2005

  1. Activity of carboplatin in patients with advanced non-small cell lung cancer pre-treated with a non-platinum combination

    Investigational New Drugs, Vol. 23, Núm. 6, pp. 597-601

2004

  1. Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation

    Cancer, Vol. 101, Núm. 10, pp. 2261-2269

2003

  1. Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes

    Investigational New Drugs, Vol. 21, Núm. 4, pp. 459-463

  2. Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: A dose-finding study

    Breast Cancer Research and Treatment, Vol. 80, Núm. 3, pp. 257-265

  3. Irinotecan in the treatment of advanced colorectal cancer in patients pretreated with fluorouracil-based chemotherapy: A study to determine recommendable therapeutic dosage

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 26, Núm. 2, pp. 107-111

  4. Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy

    Annals of Oncology, Vol. 14, Núm. 11, pp. 1640-1647

2002

  1. Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer

    Investigational New Drugs, Vol. 20, Núm. 3, pp. 317-326

  2. Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer

    Investigational New Drugs, Vol. 20, Núm. 1, pp. 73-82

2001

  1. Interleukin-2-based home therapy in advanced renal cell cancer (ARCC)

    Oncologia, Vol. 24, Núm. 1, pp. 33-36

2000

  1. A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

    Breast Cancer Research and Treatment, Vol. 62, Núm. 2, pp. 127-133